Global Robotic Prosthetics Market Professional Survey Report 2017
shows the global robotic prosthetics market size will reach USD 1586.15
million in 2022. The key factors driving this market are global
increase in the number of amputation cases, technological advancements,
and initiatives taken by government organizations, such as Centers for
Disease Control and nonprofit organizations like Amputee Coalition, to
facilitate funding and purchases of prosthetic devices.
On the basis of technology, the market is segmented into Microprocessor Controlled (MPC) prosthetics and myoelectric prosthetics. In 2016, MPC prosthetics accounted for the maximum revenue share of the market owing to the easy availability of products that use this technology as opposed to myoelectric products. Increasing clinical research for developing novel devices that use MPC technology is also one of the key factors responsible for the largest revenue share held by this segment. RHEO KNEE, Plie, PROPRIO, Elan, and Knee Joint C-Leg are some MPC devices that are commercially available. Myoelectric prosthetics segment is expected to grow at a lucrative rate of approximately 10.3% over the forecast period.
In 2016, lower body extremity segment held majority of the revenue share of robotic prosthetics market owing to the huge commercial presence of these devices and high number of lower body amputation cases across the globe. Moreover, the lower body extremity segment is anticipated to grow at the fastest rate over the forecast period owing to rising prevalence of diabetes and vascular disease, which further leads to an increase in the number of lower limb amputation cases globally.
The demand for lower body prosthetics by geriatric population is growing at a rapid pace, which is one of the crucial factors anticipated to increase the use of the devices. Technological advancements in upper and lower limb prosthetics and growing adoption of advanced polymers in novel prosthetics are among the few factors that are anticipated to propel the demand for these devices. According to various reports published, approximately 80% of all lower extremity amputations are dysvascular amputations.
North America held the major revenue share followed by Europe in 2016. Increasing healthcare expenditure, growing adoption of technologically advanced products, surging amputee population, and favorable government initiatives with regard to robotic technology are some of the key drivers responsible for the largest revenue share held by North America.
However, Asia Pacific is expected to grow at the fastest rate in the coming years due to rapid economic development, rising geriatric population, high diabetic population, and improving healthcare infrastructure in emerging economies such as India, Philippines, Indonesia, and China. Rising number of amputees and increasing incidence of foot ulcers associated with diabetes drive the demand for robotic prosthetics in the market. According to National Healthcare Group, Singapore has one of the world’s highest rates of diabetes related lower extremity amputation. The abovementioned factors are responsible for driving the demand for technologically advanced prosthetics.
Contact Us：+86-1082945717
Email:sales@qyresearchglobal.com
On the basis of technology, the market is segmented into Microprocessor Controlled (MPC) prosthetics and myoelectric prosthetics. In 2016, MPC prosthetics accounted for the maximum revenue share of the market owing to the easy availability of products that use this technology as opposed to myoelectric products. Increasing clinical research for developing novel devices that use MPC technology is also one of the key factors responsible for the largest revenue share held by this segment. RHEO KNEE, Plie, PROPRIO, Elan, and Knee Joint C-Leg are some MPC devices that are commercially available. Myoelectric prosthetics segment is expected to grow at a lucrative rate of approximately 10.3% over the forecast period.
In 2016, lower body extremity segment held majority of the revenue share of robotic prosthetics market owing to the huge commercial presence of these devices and high number of lower body amputation cases across the globe. Moreover, the lower body extremity segment is anticipated to grow at the fastest rate over the forecast period owing to rising prevalence of diabetes and vascular disease, which further leads to an increase in the number of lower limb amputation cases globally.
The demand for lower body prosthetics by geriatric population is growing at a rapid pace, which is one of the crucial factors anticipated to increase the use of the devices. Technological advancements in upper and lower limb prosthetics and growing adoption of advanced polymers in novel prosthetics are among the few factors that are anticipated to propel the demand for these devices. According to various reports published, approximately 80% of all lower extremity amputations are dysvascular amputations.
North America held the major revenue share followed by Europe in 2016. Increasing healthcare expenditure, growing adoption of technologically advanced products, surging amputee population, and favorable government initiatives with regard to robotic technology are some of the key drivers responsible for the largest revenue share held by North America.
However, Asia Pacific is expected to grow at the fastest rate in the coming years due to rapid economic development, rising geriatric population, high diabetic population, and improving healthcare infrastructure in emerging economies such as India, Philippines, Indonesia, and China. Rising number of amputees and increasing incidence of foot ulcers associated with diabetes drive the demand for robotic prosthetics in the market. According to National Healthcare Group, Singapore has one of the world’s highest rates of diabetes related lower extremity amputation. The abovementioned factors are responsible for driving the demand for technologically advanced prosthetics.
Contact Us：+86-1082945717
Email:sales@qyresearchglobal.com
评论
发表评论